Company intelligence / Profile preview

Ki Health Partners

Stamford, Connecticut, United Stateskihealthpartners.com ↗

Ownership: Private
Development stage: Commercial

Overview

Ki Health Partners has managed or participated in multiple active clinical trials across neurology and related fields. Recent studies include proof-of-concept work with DaxibotulinumtoxinA for migraine prevention ("EEG paradigm"), as well as participation in multi-center trials involving lasmiditan and donanemab. The company is recognized for aggressive subject recruitment and high-quality data delivery but does not publish its own drug results since it operates as a service provider rather than a product developer.

Therapeutic areas: Men's HealthPsychiatryNeurologyCardiovascular
Modalities: DeviceDrug
Industry: Contract Research Organization

Partnerships

Pharmaceutical sponsors (small biotechs to large pharma companies)

Beyond the preview

Go deeper on Ki Health Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ki Health Partners.